EMA Management Board: highlights of October 2018 meeting

October 5, 2018 – At its 4 October 2018 meeting in London, the Management Board of the European Medicines Agency (EMA) heard an update on the Agency’s activities in the first half of 2018. In human medicine, EMA recommended the first two CAR-T cell medicines for approval in the European Union (EU). These innovative medicines present a new approach in the treatment of cancer and were also the first medicines supported through EMA’s PRIority MEdicines … (leggi tutto)